COVID-19 Vaccine (ChAdOx1-S [Recombinant]) (COVID-19 Vaccine AstraZeneca) for the Prevention of COVID-19

Date of publication: February 02, 2021 Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report is produced to present all currently available evidence considered in the assessment of Pfizer-BioNTech COVID-19 Vaccine. This continue reading : COVID-19 Vaccine (ChAdOx1-S [Recombinant]) (COVID-19 Vaccine AstraZeneca) for the Prevention of COVID-19

BNT162b2 (Pfizer-BioNTech COVID-19 Vaccine) for the prevention of COVID-19

Date of publication: February 02, 2021 Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report is produced to present all currently available evidence considered in the assessment of Pfizer-BioNTech COVID-19 Vaccine. This continue reading : BNT162b2 (Pfizer-BioNTech COVID-19 Vaccine) for the prevention of COVID-19

Use of Rapid Antigen Test Kits for the Diagnosis of COVID-19

USE OF RAPID ANTIGEN TEST KITS FOR THE DIAGNOSIS OF COVID-19 Date of publication: October 15, 2020 Objectives: Rapid review:   Use of Rapid Antigen Test Kits for the Diagnosis of COVID-19 Evidence summary:  Use of Rapid Antigen Test Kits for the Diagnosis of COVID-19 Guidance document:  Technical Requirements for SARS- CoV-2 Rapid Antigen Test Kits HTAC Recommendation Review: